ID: ALA3229633

Max Phase: Preclinical

Molecular Formula: C44H68N10O12S2

Molecular Weight: 993.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O

Standard InChI:  InChI=1S/C44H68N10O12S2/c1-8-23(4)35-41(64)53-36(24(5)55)42(65)50-29(18-32(45)57)38(61)51-30(43(66)54-15-9-10-31(54)40(63)49-27(16-22(2)3)37(60)47-20-33(46)58)21-67-68-44(6,7)19-34(59)48-28(39(62)52-35)17-25-11-13-26(56)14-12-25/h11-14,22-24,27-31,35-36,55-56H,8-10,15-21H2,1-7H3,(H2,45,57)(H2,46,58)(H,47,60)(H,48,59)(H,49,63)(H,50,65)(H,51,61)(H,52,62)(H,53,64)/t23-,24+,27-,28-,29-,30-,31-,35-,36-/m0/s1

Standard InChI Key:  JJMKMIOJYPTECZ-QYUOUNJVSA-N

Associated Targets(non-human)

Oxytocin receptor 839 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 993.22Molecular Weight (Monoisotopic): 992.4460AlogP: -1.65#Rotatable Bonds: 15
Polar Surface Area: 350.65Molecular Species: NEUTRALHBA: 14HBD: 11
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.50CX Basic pKa: CX LogP: -2.63CX LogD: -2.64
Aromatic Rings: 1Heavy Atoms: 68QED Weighted: 0.09Np Likeness Score: 0.66

References

1. Lowbridge J, Manning M, Seto J, Haldar J, Sawyer WH..  (1979)  Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.,  22  (5): [PMID:458806] [10.1021/jm00191a019]
2. Hruby VJ, Deb KK, Yamamoto DM, Hadley ME, Chan WY..  (1979)  [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor.,  22  (1): [PMID:423185] [10.1021/jm00187a002]
3. Manning M, Lowbridge J, Seto J, Haldar J, Sawyer WH..  (1978)  [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.,  21  (2): [PMID:621712] [10.1021/jm00200a007]
4. Manning M, Lowbridge J, Seto J, Haldar J, Sawyer WH..  (1978)  [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.,  21  (2): [PMID:621712] [10.1021/jm00200a007]

Source